The Claim

The probiotic Bifidobacterium longum BL21 reduces systemic inflammation in individuals diagnosed with polycystic ovary syndrome (PCOS).

What the research says

Not yet evaluated

We are still looking at what the research says.

Supports
0score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

Taking a specific probiotic called Bifidobacterium longum BL21 might help lower body-wide inflammation in women with PCOS.

See the scientific wording

The probiotic Bifidobacterium longum BL21 reduces systemic inflammation in individuals with polycystic ovary syndrome (PCOS).

What the research says

1 study

  1. Study: Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut–brain–ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection

    The study tested the same probiotic mentioned in the claim and found it lowered inflammation in mice with PCOS-like symptoms, which supports the idea that it could help reduce inflammation in people too.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.